News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search Vall d'Hebron highlights the potential of synbiotics to control irritability 22/07/2024 Genetic basis of ADHD and autism spectrum disorder impacts on school performance 31/05/2024 Four Vall d'Hebron researchers among the most cited in 2023 according to Clarivate 15/11/2023 Four Vall d'Hebron projects selected for the CaixaImpulse Health Innovation programme 17/10/2023 A genetic study indicates that ADHD is associated with lower life expectancy 09/05/2023 Largest genetic study in ADHD identifies new genome regions associated with the disorder 24/02/2023 The Multidisciplinary Committee on Pancreatic Cancer at the National Surgery Congress 11/11/2022 Four Vall d’Hebron mental health projects awarded in the 2021 TV3 La Marató charity event 03/11/2022 Research on prevention, diagnosis and treatment of adult and childhood cancer 24/09/2022 Dr Amanda Rodríguez presents her book 'Siente lo que comes' 05/04/2022 Clinical trial designed to treat locally advanced pancreatic cancer with nanoparticles 18/03/2022 New study shows the relationship between insomnia and ADHD improvement 03/03/2022 New report with the collaboration of Vall d’Hebron calls for clearer definition of treatment-resistant depression 15/12/2021 Vall d'Hebron studies the effectiveness of online interventions for cannabis addiction in young people 07/12/2021 Vall d’Hebron, committed to cancer research 23/09/2021 Families with transplanted children feel more understood due to the widespread use of prevention measures, such as masks 15/09/2021 The Multidisciplinary Pancreatic Cancer Committee has already carried out 686 assessments on 305 patients 05/09/2021 Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder 16/05/2021 Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder 28/03/2021 Self-injurious behaviors are among the main reasons why children and adolescents consult in mental health emergency room 26/03/2021 Pagination 1 2 Next › Next page Last » Last page